| 产品描述: | PKC-theta inhibitor 1 is an orally active and selective ATP-competitive inhibitor of Protein Kinase Cθ (PKCθ), with a Ki value of 6 nM. PKC-theta inhibitor 1 inhibits T-cell-mediated inflammatory responses by suppressing the release of proinflammatory cytokines (IL-2 IC50 = 0.21 μM in anti-CD3/CD28-stimulated PBMCs; IL-17 IC50 = 1 μM in CD3/CD28-stimulated Th17 cells) PKC-theta inhibitor 1 significantly reduces symptoms in mice with ongoing experimental autoimmune encephalomyelitis (EAE). PKC-theta inhibitor 1 can be used for the study of T-cell-mediated inflammatory diseases such as multiple sclerosis. |
| 体外研究: |
PKC-theta inhibitor 1 (Compound 22) 表现出强效的 PKCθ 抑制活性,其 Ki 值为 6 nM,对 PKCδ 和 PKCα 具有高选择性,选择性比率分别为 392 和 1020。 PKC-theta inhibitor 1 抑制抗 CD3/CD28 刺激的 PBMCs 中 IL-2 的释放,其 IC50 值为 0.21 μM。 PKC-theta inhibitor 1 抑制 CD3/CD28 刺激的 Th17 细胞中 IL-17 的释放,其 IC50 值为 1 μM。 PKC-theta inhibitor 1 在 Caco-2 细胞中显示出良好的渗透性,A-B 渗透率为 19 × 10-6 cm/s,外排比率 (E.R.) 为 2.4。 |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.871 ml |
14.355 ml |
28.709 ml |
| 5 mM |
0.574 ml |
2.871 ml |
5.742 ml |
| 10 mM |
0.287 ml |
1.435 ml |
2.871 ml |
| 50 mM |
0.057 ml |
0.287 ml |
0.574 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |